ReP USP - Resultado da busca

Artigo de periodico
Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability (2024)
Hernandez, Carolina Dagli; Ferreira, Glaucio Monteiro ; Freitas, Renata Caroline Costa de ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Gonçalves, Rodrigo Marques; Faludi, Andre Arpad; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Bortolin, Raul Hernandes ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacogenetics and Genomics. Unidades: FCF, IDPC
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability. Pharmacogenetics and Genomics, v. 34, n. 4, p. 91-104, 2024Tradução . . Disponível em: https://dx.doi.org/10.1097/FPC.0000000000000524. Acesso em: 23 ago. 2024.
APA
Hernandez, C. D., Ferreira, G. M., Freitas, R. C. C. de, Borges, J. B., Oliveira, V. F. de, Gonçalves, R. M., et al. (2024). Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability. Pharmacogenetics and Genomics, 34( 4), 91-104. doi:10.1097/FPC.0000000000000524
NLM
Hernandez CD, Ferreira GM, Freitas RCC de, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Marçal E da SR, Bastos GM, Bortolin RH, Hirata MH, Hirata RDC. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability [Internet]. Pharmacogenetics and Genomics. 2024 ; 34( 4): 91-104.[citado 2024 ago. 23 ] Available from: https://dx.doi.org/10.1097/FPC.0000000000000524
Vancouver
Hernandez CD, Ferreira GM, Freitas RCC de, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Marçal E da SR, Bastos GM, Bortolin RH, Hirata MH, Hirata RDC. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability [Internet]. Pharmacogenetics and Genomics. 2024 ; 34( 4): 91-104.[citado 2024 ago. 23 ] Available from: https://dx.doi.org/10.1097/FPC.0000000000000524
Artigo de periodico
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach (2023)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Silbiger, Vivian Nogueira ; Luchessi, Andre Ducati ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Molecular Biology Reports. Unidades: IDPC, FCF
Assuntos: MICRORNAS, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, v. 50, n. 11, p. 9165-9177, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11033-023-08784-9. Acesso em: 23 ago. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Borges, J. B., Oliveira, V. F. de, Hernandez, C. D., Marçal, E. da S. R., et al. (2023). LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, 50( 11), 9165-9177. doi:10.1007/s11033-023-08784-9
NLM
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 ago. 23 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Vancouver
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 ago. 23 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Assuntos: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 23 ago. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report (2021)
Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Marçal, Elisangela da Silva Rodrigues; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Borges, Jéssica Bassani ; Bastos, Gisele Medeiros ; Los, Bruna; Mori, Augusto Akira ; Bortolin, Raul Hernandes ; Ferreira, Glaucio Monteiro ; Oliveira, Victor Fernandes de ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Annals of Translational Medicine. Unidades: IDPC, FCF
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, v. 9, n. 1, p. 1-8 art. 76, 2021Tradução . . Disponível em: https://doi.org/10.21037/atm-20-5540. Acesso em: 23 ago. 2024.
APA
Hernandez, C. D., Freitas, R. C. C. de, Marçal, E. da S. R., Gonçalves, R. M., Faludi, A. A., Borges, J. B., et al. (2021). Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, 9( 1), 1-8 art. 76. doi:10.21037/atm-20-5540
NLM
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 ago. 23 ] Available from: https://doi.org/10.21037/atm-20-5540
Vancouver
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 ago. 23 ] Available from: https://doi.org/10.21037/atm-20-5540

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Agência de fomento

Afiliação dos autores externos não normalizada